Amantadine Hydrochloride
- Product NDC
- 73152-075
- 11-digit product format
- 731520075
- Labeler code
- 73152
- Product ID
- 73152-075_bbb43284-8884-d38e-e053-2995a90a1dcd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amantadine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Athem LLC
- Application
- ANDA210215
- Marketing category
- ANDA
- Marketing start
- 2021-02-19
- Marketing end
- 0000-00-00
- Substance
- AMANTADINE HYDROCHLORIDE
- Active strength
- 100 1/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73152-075-01 | Amantadine Hydrochloride | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
| 73152-075-05 | Amantadine Hydrochloride | 500 in 1 BOTTLE | TABLET | 500 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73152-075 | AMANTADINE HYDROCHLORIDE TABLET [ATHEM LLC] | 2 | Legacy NDC, 2 package rows | 20210220_5ae327cf-8946-4682-9025-64653673e367.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73152-075-01 | 73152007501 | 100 TABLET in 1 BOTTLE (73152-075-01) | 100 tablet | 2021-02-19 | 0000-00-00 | No | No | Current |
| 73152-075-05 | 73152007505 | 500 TABLET in 1 BOTTLE (73152-075-05) | 500 tablet | 2021-02-19 | 0000-00-00 | No | No | Current |